CN105942068A - 一种高丽红参汤的制备方法 - Google Patents
一种高丽红参汤的制备方法 Download PDFInfo
- Publication number
- CN105942068A CN105942068A CN201610360309.0A CN201610360309A CN105942068A CN 105942068 A CN105942068 A CN 105942068A CN 201610360309 A CN201610360309 A CN 201610360309A CN 105942068 A CN105942068 A CN 105942068A
- Authority
- CN
- China
- Prior art keywords
- radix ginseng
- ginseng
- water
- soup
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000014347 soups Nutrition 0.000 title claims abstract description 35
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 claims abstract description 97
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 92
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 92
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 39
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000000284 extract Substances 0.000 claims abstract description 18
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000000605 extraction Methods 0.000 claims abstract description 10
- 230000001954 sterilising effect Effects 0.000 claims abstract description 10
- 108010011485 Aspartame Proteins 0.000 claims abstract description 9
- 239000000605 aspartame Substances 0.000 claims abstract description 9
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 9
- 229960003438 aspartame Drugs 0.000 claims abstract description 9
- 235000010357 aspartame Nutrition 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 9
- 229960003080 taurine Drugs 0.000 claims abstract description 9
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 9
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims abstract description 7
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 7
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 7
- 239000000230 xanthan gum Substances 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 241000208340 Araliaceae Species 0.000 claims abstract 16
- 239000008213 purified water Substances 0.000 claims description 14
- 239000011265 semifinished product Substances 0.000 claims description 14
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 229910000831 Steel Inorganic materials 0.000 claims description 8
- 239000003651 drinking water Substances 0.000 claims description 8
- 235000020188 drinking water Nutrition 0.000 claims description 8
- 239000010959 steel Substances 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 238000003860 storage Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims description 6
- 238000007599 discharging Methods 0.000 claims description 6
- 238000010025 steaming Methods 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000005352 clarification Methods 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 3
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 4
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract description 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract description 2
- 238000012827 research and development Methods 0.000 abstract description 2
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 1
- 235000015165 citric acid Nutrition 0.000 abstract 1
- 229960004106 citric acid Drugs 0.000 abstract 1
- 238000005538 encapsulation Methods 0.000 abstract 1
- 238000011049 filling Methods 0.000 abstract 1
- 235000013402 health food Nutrition 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 description 81
- 230000000694 effects Effects 0.000 description 17
- 230000001093 anti-cancer Effects 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 239000003005 anticarcinogenic agent Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 229930194248 Licoflavone Natural products 0.000 description 2
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 2
- 241001106041 Lycium Species 0.000 description 2
- 229930192392 Mitomycin Natural products 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000012201 sexual and gender identity disease Diseases 0.000 description 2
- 208000015891 sexual disease Diseases 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007688 immunotoxicity Effects 0.000 description 1
- 231100000386 immunotoxicity Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明所属食品及保健食品研究开发技术领域。本发明涉及一种高丽红参汤的制备方法。将韩国高丽鲜参制成高丽红参;将高丽红参用水提取,得到的红参提取液;将大枣、茯苓、枸杞子、甘草用水提取,浓缩成为中药浸膏;将低聚异麦芽糖、牛磺酸、柠檬酸、黄原胶、阿斯巴甜与红参提取液和中药浸膏混合均匀,制成高丽红参汤,过滤,杀菌,灌装,灌封后杀菌。本发明产品具有强身健体的功能。
Description
技术领域
本发明所属食品及保健食品研究开发技术领域。本发明涉及一种高丽红参汤的制备方法。本发明产品具有强身健体的功能。
背景技术
1高丽红参 系由产自韩国的高丽园参经蒸、烘烤加工而成,在加工高丽红参过程中,有新的抗癌活性成分产生。高丽红参不凉也不热,属于温性;高丽参虽性温但补性强,益气助火。高丽参又分白参和红参,脾虚火旺者宜用白参,因“生用气凉,微苦补阴”;脾虚肺怯者宜用红参,“熟用气温,味甘补阳”。总体来说,高丽参更适合老年气虚症状明显的人服用,能强壮体质,增强免疫力。
高丽红参的功效:
(1)益智健脑:对记忆力减退和运动协调能力下降的人以及经常喝酒或接触带乙醇成分的食物、药物的人,高丽红参具有提高脑力工作能力、增强记忆力和改善脑缺血性障碍的功效
(2)镇痛:一些专家通过做传感神经细胞试验发现,高丽参对身体各种疼痛症状都有所帮助。
(3)防癌和抗癌:高丽红参的皂苷成分和非皂苷成分有抑制多种癌细胞的增殖活性,同时也可抑制癌细胞转移。另外,高丽红参与抗癌剂同服用,抗癌效果要好于单独用抗癌剂(丝裂霉素)。这是因为肿瘤化疗中癌细胞易形成耐受,高丽红参与抗癌剂同服用,增强对癌细胞的杀伤力、减轻抗癌剂的副作用。(4)增强免疫力:高丽红参提取物可恢复因服用具有免疫毒性的抗癌剂(丝裂霉素)而下降的细胞性免疫反应,尤其乙醚提取物可激活或增强细胞性免疫,及自然杀伤细胞的活性,对提高免疫力有很大的功效。
(5)控制糖尿病:高丽红参含有促进胰岛素分泌和类似胰岛素作用的物质,其中人参皂苷能改善高血糖,有效地控制糖尿病的发生。
(6)健肝:高丽参成分中有抗肝炎活性,具有解毒、保护肝脏及促进肝再生、恢复的作用。此外,高丽红参还有解酒、消除宿醉的作用。
(7)调节血压:高丽红参具有扩张血管作用,能改善血液循环,其中的皂苷成分通过促进血管内皮细胞释放一氧化氮,可达到降血压作用。
(8)抗疲劳及抗压:经研究发现,持续服用高丽红参可以提高运动能力和缓解疲劳,对促进运动员疲劳累积的恢复和预防运动性贫血有很大帮助;此外,高丽红参还可以增强对低温(5℃、O℃、-10℃)及高温(35℃)等不利环境的耐受力,通过对压力或环境变化进行精妙调节,提高抗压能力,维持机体稳定性。
(9)改善女性更年期障碍:据调查,有更年期障碍症状的女性在服用高丽红参后,有80%的人承认服用高丽红参后症状明显改善。专家称,这些女性如根据症状来调整用量,还可提高疗效。
(10)改善男性性功能障碍:高丽红参可防止因压力导致的男性性功能障碍。经临床试验,勃起障碍患者(90人)服用高丽红参后,在勃起程度、性欲及满意度等方面都有所改善。
(11) 抗氧化及抗衰老:高丽红参具有抑制有害活性氧的增多和脂类过氧化的抗氧化效果。
2 大枣 又名红枣、干枣、枣子,起源于中国,在中国已有八千多年的种植历史,自古以来就被列为“五果”(栗、桃、李、杏、枣)之一。大枣富含蛋白质、脂肪、糖类、胡萝卜素、B族维生素、维生素C、维生素P以及钙、磷、铁和环磷酸腺苷等营养成分。其中维生素C的含量在果品中名列前茅,有维生素王之美称。
3茯苓 又称玉灵、茯灵,是真菌茯苓的干燥菌核,常寄生在松树根上,形如甘薯,球状,外皮淡棕色或黑褐色,内部粉色或白色。茯苓性味甘淡平,入心、肺、脾经。具有渗湿利水,健脾和胃,宁心安神,败毒抗癌的功效。药性平和,利湿而不伤正气。适量服食可作为春夏潮湿季节的调养佳品,可治小便不利、水肿胀满、痰饮咳逆、呕逆、恶阻、泄泻、遗精、淋浊、惊悸、健忘等症。所含茯苓酸具有增强免疫力、抗肿瘤以及镇静、降血糖等的作用。可松弛消化道平滑肌,抑制胃酸分泌,防止肝细胞坏死,抗菌等功效。
4枸杞子 是茄目茄科枸杞属(Lycium)的植物,果实称枸杞子,具有滋补肝肾,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,内热消渴,血虚萎黄,目昏不明。有降低血糖、 抗脂肪肝作用,并能抗动脉粥样硬化。有增强非特异性免疫作用,延缓衰老作用,抗肝损伤,降血糖,补肾,保肝,抗疲劳,抗肿瘤作用。
5甘草,甘草又名乌拉尔甘草,多年生草本植物,属豆科。是一种补益中草药,药食兼用品种。甘草益气补中,缓急止痛,润肺止咳,泻火解毒,调和诸药。主倦怠食少,肌瘦面黄,心悸气短,腹痛便溏,四肢挛急疼痛,脏躁,咳嗽气喘,咽喉肿痛,痈疮肿痛,小儿胎毒及药物、食物中毒。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
(1)甘草有类似肾上腺皮质激素样作用。对组胺引起的胃酸分泌过多有抑制作用;并有抗酸和缓解胃肠平滑肌痉挛作用。
(2)甘草黄酮、甘草浸膏及甘草次酸均有明显的镇咳作用;祛痰作用也较显著,其作用强度为甘草酸>甘草黄酮>甘草浸膏。
(3)甘草还有抗炎,抗过敏作用,能保护发炎的咽喉和气管粘膜。甘草浸膏和甘草酸对某些毒物有类似葡萄糖醛酸的解毒作用。
(4)甘草常用来治疗随更年期而来的症状.因为甘草里含有甘草素,是一种类似激素的化合物,它有助于平衡女性体内的激素含量。
(5)甘草所含的次酸能阻断致癌物诱发肿瘤生长的作用。
一参二果一草配合一食用菌使用制备的高丽红参汤具有强身健体的功能。
发明内容
1、一种高丽红参汤的制备方法,其特征在于其原辅料组成及重量配比为:
(1)韩国产高丽鲜参4-5年根20-800kg、大枣13.5-14.5kg、茯苓4.5-4.7kg、枸杞子2.2-2.4kg、甘草1.7-1.9kg、低聚异麦芽糖 11-13kg、牛磺酸0.4-0.6kg、柠檬酸0.4-0.6kg、黄原胶0.2-0.4kg、阿斯巴甜0.1-0.3kg、纯化水适量,制成1000L高丽红参汤;
(2)取(1)中韩国高丽鲜参4-5年根20-800kg,用流动饮用水洗净,放置蒸参柜中,加热升温60~95℃需要0.5-1h;95~98℃蒸2h;98~66℃,焖1-1.5h,取出,放置3.5-4h,成为高丽红参半成品;
(3)将(2)中的高丽红参半成品放入烘干室中,60-70℃干燥8-10h,每隔0.5-1h鼓风排潮1次,取出,下须;
(4)将(3)中的高丽红参半成品在夜间室外放置11-12h;
(5)将(4)中高丽红参半成品放入烘干室中,51-55℃干燥11-12h,每隔2-3h鼓风排潮1次,取出,即为高丽红参,重量为5-200kg;
(6)将(5)中高丽红参放入不锈钢提取罐中,分别加入16倍水、8倍水、8倍水、8倍水,在80℃-100℃共提取4次,将4次得到的红参提取液静置,过滤,过滤后的红参提取液立即用于调配,剩余残渣经烘箱80℃-100℃烘干后入库;
(7)将(1)中大枣13.5-14.5 kg、茯苓4.5-4.7kg、枸杞子2.2-2.4kg、甘草1.7-1.9kg,用流动饮用水洗净,放入不锈钢提取罐中,用8倍纯化水浸泡1h,第1次提取3h,提取温度为100℃;再用6倍水、4倍水分别提取2h,提取温度为100℃;
(8)将(7)中3次提取液合并,静置,过滤,剩余残渣经烘箱80℃-100℃烘干后入库;
(9)将(8)中过滤液在80℃-85℃浓缩成为中药浸膏,将中药浸膏移入0℃的冷库保存;
(10)将包装瓶、瓶盖用纯化水清洗,在100℃烘干1-1.5h后使用;
(11)将(1)中低聚异麦芽糖 11-13kg、牛磺酸0.4-0.6kg、柠檬酸0.4-0.6kg、黄原胶0.2-0.4kg、阿斯巴甜0.1-0.3kg与(6)中过滤后的红参提取液和(9)中中药浸膏放入调配罐中混合均匀,加入适量纯化水,搅拌60-70分钟,混匀,制成1000L高丽红参汤;
(12)将(11)中高丽红参汤经硅藻土过滤机过滤,得到澄清的高丽红参汤过滤液;
(13)将(12)中高丽红参汤过滤液杀菌,杀菌温度在90℃-100℃,时间为90-100分钟,立即进行灌装,瓶装量为52-54mL;
(14)将(13)中灌封后的52-54mL红参汤杀菌,杀菌温度在90℃-100℃,时间为60-70分钟。
具体实施方式
本发明所述的涉及一种高丽红参汤的制备方法包括以下实施例,下面的实施例可进一步说明本发明,但不以任何方式限制本发明。
实施例1:
1、一种高丽红参汤的制备方法,其特征在于其原辅料组成及重量配比为:
(1)韩国产高丽鲜参4年根20kg、大枣13.5kg、茯苓4.5kg、枸杞子2.2kg、甘草1.7kg、低聚异麦芽糖 11kg、牛磺酸0.4kg、柠檬酸0.4kg、黄原胶0.2kg、阿斯巴甜0.1kg、纯化水适量,制成1000L高丽红参汤;
(2)取(1)中韩国高丽鲜参4年根20kg,用流动饮用水洗净,放置蒸参柜中,加热升温60~95℃需要0.5h;95~98℃蒸2h;98~66℃,焖1h,取出,放置3.5h,成为高丽红参半成品;
(3)将(2)中的高丽红参半成品放入烘干室中,60℃干燥10h,每隔0.5h鼓风排潮1次,取出,下须;
(4)将(3)中的高丽红参半成品在夜间室外放置11h;
(5)将(4)中高丽红参半成品放入烘干室中,51℃干燥12h,每隔2h鼓风排潮1次,取出,即为高丽红参,重量为5kg;
(6)将(5)中高丽红参放入不锈钢提取罐中,分别加入16倍水、8倍水、8倍水、8倍水,在80℃℃共提取4次,将4次得到的红参提取液静置,过滤,过滤后的红参提取液立即用于调配,剩余残渣经烘箱80℃烘干后入库;
(7)将(1)中大枣13.5kg、茯苓4.5kg、枸杞子2.2kg、甘草1.7kg,用流动饮用水洗净,放入不锈钢提取罐中,用8倍纯化水浸泡1h,第1次提取3h,提取温度为100℃;再用6倍水、4倍水分别提取2h,提取温度为100℃;
(8)将(7)中3次提取液合并,静置,过滤,剩余残渣经烘箱80℃烘干后入库;
(9)将(8)中过滤液在80℃浓缩成为中药浸膏,将中药浸膏移入0℃的冷库保存;
(10)将包装瓶、瓶盖用纯化水清洗,在100℃烘干1h后使用;
(11)将(1)中低聚异麦芽糖 11kg、牛磺酸0.4kg、柠檬酸0.4kg、黄原胶0.2kg、阿斯巴甜0.1kg与(6)中过滤后的红参提取液和(9)中中药浸膏放入调配罐中混合均匀,加入适量纯化水,搅拌60分钟,混匀,制成1000L高丽红参汤;
(12)将(11)中高丽红参汤经硅藻土过滤机过滤,得到澄清的高丽红参汤过滤液;
(13)将(12)中高丽红参汤过滤液杀菌,杀菌温度在90℃,时间为100分钟,立即进行灌装,瓶装量为52mL;
(14)将(13)中灌封后的52mL红参汤杀菌,杀菌温度在90℃,时间为70分钟。
实施例2:
1、一种高丽红参汤的制备方法,其特征在于其原辅料组成及重量配比为:
(1)韩国产高丽鲜参5年根800kg、大枣14.5kg、茯苓4.7kg、枸杞子2.4kg、甘草1.9kg、低聚异麦芽糖13kg、牛磺酸0.6kg、柠檬酸0.6kg、黄原胶0.4kg、阿斯巴甜0.3kg、纯化水适量,制成1000L高丽红参汤;
(2)取(1)中韩国高丽鲜参5年根800kg,用流动饮用水洗净,放置蒸参柜中,加热升温60~95℃需要1h;95~98℃蒸2h;98~66℃,焖1.5h,取出,放置4h,成为高丽红参半成品;
(3)将(2)中的高丽红参半成品放入烘干室中,70℃干燥8h,每隔1h鼓风排潮1次,取出,下须;
(4)将(3)中的高丽红参半成品在夜间室外放置12h;
(5)将(4)中高丽红参半成品放入烘干室中,55℃干燥11h,每隔3h鼓风排潮1次,取出,即为高丽红参,重量为200kg;
(6)将(5)中高丽红参放入不锈钢提取罐中,分别加入16倍水、8倍水、8倍水、8倍水,在100℃共提取4次,将4次得到的红参提取液静置,过滤,过滤后的红参提取液立即用于调配,剩余残渣经烘箱100℃烘干后入库;
(7)将(1)中大枣14.5 kg、茯苓4.7kg、枸杞子2.4kg、甘草1.9kg,用流动饮用水洗净,放入不锈钢提取罐中,用8倍纯化水浸泡1h,第1次提取3h,提取温度为100℃;再用6倍水、4倍水分别提取2h,提取温度为100℃;
(8)将(7)中3次提取液合并,静置,过滤,剩余残渣经烘箱100℃烘干后入库;
(9)将(8)中过滤液在85℃浓缩成为中药浸膏,将中药浸膏移入0℃的冷库保存;
(10)将包装瓶、瓶盖用纯化水清洗,在100℃烘干1.5h后使用;
(11)将(1)中低聚异麦芽糖13kg、牛磺酸0.6kg、柠檬酸0.6kg、黄原胶0.4kg、阿斯巴甜0.3kg与(6)中过滤后的红参提取液和(9)中中药浸膏放入调配罐中混合均匀,加入适量纯化水,搅拌70分钟,混匀,制成1000L高丽红参汤;
(12)将(11)中高丽红参汤经硅藻土过滤机过滤,得到澄清的高丽红参汤过滤液;
(13)将(12)中高丽红参汤过滤液杀菌,杀菌温度在100℃,时间为90分钟,立即进行灌装,瓶装量为54mL;
(14)将(13)中灌封后的54mL红参汤杀菌,杀菌温度在100℃,时间为60分钟。
Claims (1)
1.一种高丽红参汤的制备方法,其特征在于其原辅料组成及重量配比为:
(1)韩国产高丽鲜参4-5年根20-800kg、大枣13.5-14.5kg、茯苓4.5-4.7kg、枸杞子2.2-2.4kg、甘草1.7-1.9kg、低聚异麦芽糖 11-13kg、牛磺酸0.4-0.6kg、柠檬酸0.4-0.6kg、黄原胶0.2-0.4kg、阿斯巴甜0.1-0.3kg、纯化水适量,制成1000L高丽红参汤;
(2)取(1)中韩国高丽鲜参4-5年根20-800kg,用流动饮用水洗净,放置蒸参柜中,加热升温60~95℃需要0.5-1h;95~98℃蒸2h;98~66℃,焖1-1.5h,取出,放置3.5-4h,成为高丽红参半成品;
(3)将(2)中的高丽红参半成品放入烘干室中,60-70℃干燥8-10h,每隔0.5-1h鼓风排潮1次,取出,下须;
(4)将(3)中的高丽红参半成品在夜间室外放置11-12h;
(5)将(4)中高丽红参半成品放入烘干室中,51-55℃干燥11-12h,每隔2-3h鼓风排潮1次,取出,即为高丽红参,重量为5-200kg;
(6)将(5)中高丽红参放入不锈钢提取罐中,分别加入16倍水、8倍水、8倍水、8倍水,在80℃-100℃共提取4次,将4次得到的红参提取液静置,过滤,过滤后的红参提取液立即用于调配,剩余残渣经烘箱80℃-100℃烘干后入库;
(7)将(1)中大枣13.5-14.5 kg、茯苓4.5-4.7kg、枸杞子2.2-2.4kg、甘草1.7-1.9kg,用流动饮用水洗净,放入不锈钢提取罐中,用8倍纯化水浸泡1h,第1次提取3h,提取温度为100℃;再用6倍水、4倍水分别提取2h,提取温度为100℃;
(8)将(7)中3次提取液合并,静置,过滤,剩余残渣经烘箱80℃-100℃烘干后入库;
(9)将(8)中过滤液在80℃-85℃浓缩成为中药浸膏,将中药浸膏移入0℃的冷库保存;
(10)将包装瓶、瓶盖用纯化水清洗,在100℃烘干1-1.5h后使用;
(11)将(1)中低聚异麦芽糖 11-13kg、牛磺酸0.4-0.6kg、柠檬酸0.4-0.6kg、黄原胶0.2-0.4kg、阿斯巴甜0.1-0.3kg与(6)中过滤后的红参提取液和(9)中中药浸膏放入调配罐中混合均匀,加入适量纯化水,搅拌60-70分钟,混匀,制成1000L高丽红参汤;
(12)将(11)中高丽红参汤经硅藻土过滤机过滤,得到澄清的高丽红参汤过滤液;
(13)将(12)中高丽红参汤过滤液杀菌,杀菌温度在90℃-100℃,时间为90-100分钟,立即进行灌装,瓶装量为52-54mL;
(14)将(13)中灌封后的52-54mL红参汤杀菌,杀菌温度在90℃-100℃,时间为60-70分钟。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610360309.0A CN105942068A (zh) | 2016-05-28 | 2016-05-28 | 一种高丽红参汤的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610360309.0A CN105942068A (zh) | 2016-05-28 | 2016-05-28 | 一种高丽红参汤的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105942068A true CN105942068A (zh) | 2016-09-21 |
Family
ID=56910898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610360309.0A Pending CN105942068A (zh) | 2016-05-28 | 2016-05-28 | 一种高丽红参汤的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105942068A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108936678A (zh) * | 2018-08-08 | 2018-12-07 | 深圳极醇健康产业股份有限公司 | 一种益生菌胶囊及其制备方法 |
CN108977300A (zh) * | 2017-05-31 | 2018-12-11 | 环翠楼红参生物科技股份有限公司 | 一种红参发酵酒的制备方法 |
CN109619590A (zh) * | 2019-03-01 | 2019-04-16 | 长沙每日滋养健康科技有限公司 | 一种即食高丽参膏的制造方法 |
CN113115939A (zh) * | 2019-12-31 | 2021-07-16 | 黄彰夏 | 保健食品用组合物及其制备方法 |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101849596A (zh) * | 2010-02-26 | 2010-10-06 | 湖北中烟工业有限责任公司 | 一种滋养补气保健茶及制作方法 |
CN103564572A (zh) * | 2013-11-22 | 2014-02-12 | 威海环翠楼红参科技有限公司 | 一种高丽红参汤的制备方法 |
CN103689602A (zh) * | 2014-01-06 | 2014-04-02 | 威海环翠楼红参科技有限公司 | 一种高丽红参口服液的制备方法 |
CN103689743A (zh) * | 2014-01-07 | 2014-04-02 | 威海环翠楼红参科技有限公司 | 一种高丽红参桑椹饮料的制备方法 |
CN103689742A (zh) * | 2014-01-07 | 2014-04-02 | 威海环翠楼红参科技有限公司 | 一种高丽红参无花果饮料的制备方法 |
CN103719660A (zh) * | 2014-01-06 | 2014-04-16 | 威海环翠楼红参科技有限公司 | 一种韩国高丽红参切片蜜片的加工工艺 |
CN103750425A (zh) * | 2014-01-06 | 2014-04-30 | 威海环翠楼红参科技有限公司 | 一种高丽红参罗汉果汤的制备方法 |
CN104783463A (zh) * | 2014-12-16 | 2015-07-22 | 青岛东昌源仪器有限公司 | 一种双层眼镜盒 |
CN104783163A (zh) * | 2015-04-27 | 2015-07-22 | 威海环翠楼红参科技有限公司 | 一种新资源食品高丽红参破壁微米颗粒制剂的制备方法 |
CN104783162A (zh) * | 2015-04-27 | 2015-07-22 | 威海环翠楼红参科技有限公司 | 一种新资源食品高丽红参破壁微米颗粒的制备方法 |
CN104824657A (zh) * | 2015-06-05 | 2015-08-12 | 威海环翠楼红参科技有限公司 | 一种新资源食品高丽红参破壁粉的制备方法 |
CN105495602A (zh) * | 2016-01-04 | 2016-04-20 | 环翠楼红参生物科技股份有限公司 | 一种高丽红参细胞破壁超微粉颗粒的制备方法 |
CN105595336A (zh) * | 2016-01-04 | 2016-05-25 | 环翠楼红参生物科技股份有限公司 | 一种高丽红参枸杞子细胞破壁超微粉的制备方法 |
-
2016
- 2016-05-28 CN CN201610360309.0A patent/CN105942068A/zh active Pending
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101849596A (zh) * | 2010-02-26 | 2010-10-06 | 湖北中烟工业有限责任公司 | 一种滋养补气保健茶及制作方法 |
CN103564572A (zh) * | 2013-11-22 | 2014-02-12 | 威海环翠楼红参科技有限公司 | 一种高丽红参汤的制备方法 |
CN103719660A (zh) * | 2014-01-06 | 2014-04-16 | 威海环翠楼红参科技有限公司 | 一种韩国高丽红参切片蜜片的加工工艺 |
CN103689602A (zh) * | 2014-01-06 | 2014-04-02 | 威海环翠楼红参科技有限公司 | 一种高丽红参口服液的制备方法 |
CN103750425A (zh) * | 2014-01-06 | 2014-04-30 | 威海环翠楼红参科技有限公司 | 一种高丽红参罗汉果汤的制备方法 |
CN103689743A (zh) * | 2014-01-07 | 2014-04-02 | 威海环翠楼红参科技有限公司 | 一种高丽红参桑椹饮料的制备方法 |
CN103689742A (zh) * | 2014-01-07 | 2014-04-02 | 威海环翠楼红参科技有限公司 | 一种高丽红参无花果饮料的制备方法 |
CN104783463A (zh) * | 2014-12-16 | 2015-07-22 | 青岛东昌源仪器有限公司 | 一种双层眼镜盒 |
CN104783163A (zh) * | 2015-04-27 | 2015-07-22 | 威海环翠楼红参科技有限公司 | 一种新资源食品高丽红参破壁微米颗粒制剂的制备方法 |
CN104783162A (zh) * | 2015-04-27 | 2015-07-22 | 威海环翠楼红参科技有限公司 | 一种新资源食品高丽红参破壁微米颗粒的制备方法 |
CN104824657A (zh) * | 2015-06-05 | 2015-08-12 | 威海环翠楼红参科技有限公司 | 一种新资源食品高丽红参破壁粉的制备方法 |
CN105495602A (zh) * | 2016-01-04 | 2016-04-20 | 环翠楼红参生物科技股份有限公司 | 一种高丽红参细胞破壁超微粉颗粒的制备方法 |
CN105595336A (zh) * | 2016-01-04 | 2016-05-25 | 环翠楼红参生物科技股份有限公司 | 一种高丽红参枸杞子细胞破壁超微粉的制备方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108977300A (zh) * | 2017-05-31 | 2018-12-11 | 环翠楼红参生物科技股份有限公司 | 一种红参发酵酒的制备方法 |
CN108936678A (zh) * | 2018-08-08 | 2018-12-07 | 深圳极醇健康产业股份有限公司 | 一种益生菌胶囊及其制备方法 |
CN109619590A (zh) * | 2019-03-01 | 2019-04-16 | 长沙每日滋养健康科技有限公司 | 一种即食高丽参膏的制造方法 |
CN113115939A (zh) * | 2019-12-31 | 2021-07-16 | 黄彰夏 | 保健食品用组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105582333A (zh) | 一种养生补肾黄秋葵酒及其制备方法 | |
CN104026286A (zh) | 一种清火泡袋茶 | |
CN101269153A (zh) | 一种解酒组合物及其制备方法 | |
CN111956753B (zh) | 一种药食同源的中药组合物及其制备方法和应用 | |
CN105265672B (zh) | 一种核桃分心木茶的生产方法 | |
CN105543052A (zh) | 一种养生补肾黄秋葵酒及其制备方法 | |
CN105942068A (zh) | 一种高丽红参汤的制备方法 | |
CN103719660A (zh) | 一种韩国高丽红参切片蜜片的加工工艺 | |
CN103689152B (zh) | 一种补肾清肝凉茶及其制备方法 | |
CN103349121B (zh) | 降三高保健茶及其制备方法 | |
CN103725467B (zh) | 一种高丽参红葡萄酒的制备方法 | |
WO2016006852A1 (ko) | 천연물 약재가 함유된 기능성 커피 및 이의 제조방법 | |
CN103564572B (zh) | 一种高丽红参汤的制备方法 | |
CN105524805A (zh) | 一种高丽红参猴头菇酒的制备方法 | |
CN104187714B (zh) | 一种高丽红参膳食纤维膨化粉的制备方法 | |
CN103704458B (zh) | 一种高丽参蜜片的加工工艺 | |
CN102746978B (zh) | 一种抗衰老保健药酒 | |
CN105746775A (zh) | 一种含罗汉果保健茶 | |
CN103689602B (zh) | 一种高丽红参口服液的制备方法 | |
CN103750425B (zh) | 一种高丽红参罗汉果汤的制备方法 | |
CN106421519A (zh) | 一种保健药酒 | |
CN111686218A (zh) | 一种调理气虚体质的药食同源中药组合物及其制备方法 | |
CN104031805A (zh) | 一种秋季调和养生酒及其制备方法 | |
CN103719499A (zh) | 一种高丽红参茶的制备方法 | |
CN103704840B (zh) | 一种高丽红参青果饮料的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160921 |
|
WD01 | Invention patent application deemed withdrawn after publication |